AP Pharma (APPA)

Must be logged in to add this company to your watchlist.

Click here to login.

APPA - NASDAQ - 3/11/2010 8:00 PM

1.70
Change -0.07
% Change -3.95%
Market Cap Revenue Growth Profit Margin Cash
$53.35M 1766.67% -108.04% $1.59M
3802 / 4696 11 / 4687 4402 / 4693 3859 / 4139

For the September 2009 quarter, AP Pharma spent 127.03% of gross profits on R&D and 81.98% on SGA expenses. Revenues rose 1766.67% year-over-year to $1.12M. The company is trading at an unknown amount times earnings(PE) and 45.99 times revenue(PSR). At the end of September 2009, AP Pharma had $1.59M in cash on hand and $0 in long-term debt. On 11/16/2009, AP Pharma reported net loss of $1.21M, with diluted earnings per share of $-0.04.

Valuation

Add More Charts

Price

Current stock price.

PE Ratio

Price paid for a share relative to the annual income earned.

Price to Sales Ratio: 45.99

Market cap divided by revenue.

Growth & Profitability

Add More Charts

Revenue Growth: 1766.67%

Revenue growth year-over-year.

Earnings per Share: $-0.04

Portion of profit allocated to each outstanding share of common stock.

Profit Margin: -108.04%

Margin made on every dollar of revenue.

Fundamentals

Add More Charts

Income Statement

Summary of revenues, expenses & profits.

Balance Sheet

Company's assets, liabilities & shareholders' equity at a specific point in time.

Cash Flow

Cash inflows arise from one of three activities - operations, financing, or investing.